Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Translational and reverse translational research on the role of stress in drug craving and relapse.

Sinha R, Shaham Y, Heilig M.

Psychopharmacology (Berl). 2011 Nov;218(1):69-82. doi: 10.1007/s00213-011-2263-y. Epub 2011 Apr 15. Review.

2.

The necessity of α4* nicotinic receptors in nicotine-driven behaviors: dissociation between reinforcing and motor effects of nicotine.

Cahir E, Pillidge K, Drago J, Lawrence AJ.

Neuropsychopharmacology. 2011 Jun;36(7):1505-17. doi: 10.1038/npp.2011.35. Epub 2011 Mar 23.

3.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
4.

Functional nicotinic acetylcholine receptors containing α6 subunits are on GABAergic neuronal boutons adherent to ventral tegmental area dopamine neurons.

Yang K, Buhlman L, Khan GM, Nichols RA, Jin G, McIntosh JM, Whiteaker P, Lukas RJ, Wu J.

J Neurosci. 2011 Feb 16;31(7):2537-48. doi: 10.1523/JNEUROSCI.3003-10.2011.

5.

Habenular α5 nicotinic receptor subunit signalling controls nicotine intake.

Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ.

Nature. 2011 Mar 31;471(7340):597-601. doi: 10.1038/nature09797. Epub 2011 Jan 30.

6.

Blocking α4β2 and α7 nicotinic acetylcholine receptors inhibits the reinstatement of morphine-induced CPP by drug priming in mice.

Feng B, Xing JH, Jia D, Liu SB, Guo HJ, Li XQ, He XS, Zhao MG.

Behav Brain Res. 2011 Jun 20;220(1):100-5. doi: 10.1016/j.bbr.2011.01.040. Epub 2011 Jan 28.

PMID:
21277332
7.

bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.

Wooters TE, Smith AM, Pivavarchyk M, Siripurapu KB, McIntosh JM, Zhang Z, Crooks PA, Bardo MT, Dwoskin LP.

Br J Pharmacol. 2011 May;163(2):346-57. doi: 10.1111/j.1476-5381.2011.01220.x.

8.

Cholinergic interneurons control local circuit activity and cocaine conditioning.

Witten IB, Lin SC, Brodsky M, Prakash R, Diester I, Anikeeva P, Gradinaru V, Ramakrishnan C, Deisseroth K.

Science. 2010 Dec 17;330(6011):1677-81. doi: 10.1126/science.1193771.

9.

Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats.

Chatterjee S, Steensland P, Simms JA, Holgate J, Coe JW, Hurst RS, Shaffer CL, Lowe J, Rollema H, Bartlett SE.

Neuropsychopharmacology. 2011 Feb;36(3):603-15. doi: 10.1038/npp.2010.191. Epub 2010 Nov 3.

10.

Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial.

Tonstad S, Holme I, Tønnesen P.

Nicotine Tob Res. 2011 Jan;13(1):1-6. doi: 10.1093/ntr/ntq191. Epub 2010 Nov 1.

PMID:
21041839
11.
12.

Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticity on dopamine neurons in the ventral tegmental area.

Gao M, Jin Y, Yang K, Zhang D, Lukas RJ, Wu J.

J Neurosci. 2010 Oct 13;30(41):13814-25. doi: 10.1523/JNEUROSCI.1943-10.2010.

13.

Patterns of polydrug use in Great Britain: findings from a national household population survey.

Smith GW, Farrell M, Bunting BP, Houston JE, Shevlin M.

Drug Alcohol Depend. 2011 Jan 15;113(2-3):222-8. doi: 10.1016/j.drugalcdep.2010.08.010. Epub 2010 Sep 21.

PMID:
20863629
14.

Chronic smoking, but not acute nicotine administration, modulates neural correlates of working memory.

Sutherland MT, Ross TJ, Shakleya DM, Huestis MA, Stein EA.

Psychopharmacology (Berl). 2011 Jan;213(1):29-42. doi: 10.1007/s00213-010-2013-6. Epub 2010 Sep 23.

15.

Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds.

Desai RI, Bergman J.

J Pharmacol Exp Ther. 2010 Dec;335(3):807-16. doi: 10.1124/jpet.110.173773. Epub 2010 Sep 16.

16.

Cortico-thalamic connectivity is vulnerable to nicotine exposure during early postnatal development through α4/β2/α5 nicotinic acetylcholine receptors.

Heath CJ, King SL, Gotti C, Marks MJ, Picciotto MR.

Neuropsychopharmacology. 2010 Nov;35(12):2324-38. doi: 10.1038/npp.2010.130. Epub 2010 Aug 25.

17.

Exposure of nicotine to ventral tegmental area slices induces glutamatergic synaptic plasticity on dopamine neurons.

Jin Y, Yang K, Wang H, Wu J.

Synapse. 2011 Apr;65(4):332-8. doi: 10.1002/syn.20850. Epub 2010 Nov 11.

PMID:
20730803
18.

Nicotinic acetylcholine receptor genes on chromosome 15q25.1 are associated with nicotine and opioid dependence severity.

Erlich PM, Hoffman SN, Rukstalis M, Han JJ, Chu X, Linda Kao WH, Gerhard GS, Stewart WF, Boscarino JA.

Hum Genet. 2010 Nov;128(5):491-9. doi: 10.1007/s00439-010-0876-6. Epub 2010 Aug 20.

PMID:
20725741
19.

Modes and models of forebrain cholinergic neuromodulation of cognition.

Hasselmo ME, Sarter M.

Neuropsychopharmacology. 2011 Jan;36(1):52-73. doi: 10.1038/npp.2010.104. Epub 2010 Jul 28. Review.

20.

Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption.

Hendrickson LM, Zhao-Shea R, Pang X, Gardner PD, Tapper AR.

J Neurosci. 2010 Jul 28;30(30):10169-76. doi: 10.1523/JNEUROSCI.2601-10.2010.

Supplemental Content

Support Center